ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q1Scopus Q2SCImago #9,635Gold OA

Autoimmune Diseases

Identifier (ISSN):2090-0422(Print)/2090-0430(Online)
•
Publisher:Hindawi Limited
Clarivate JCR Index Advisory: Not Indexed in Latest JCR
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend (2024–2025)

Clarivate IF trend for Autoimmune Diseases

WoS Q1
1346420241.72025
Annual Impact Factor Metric
Current (2025):1.7
Scopus SJR & RankScopus Q2
0.611
#9,635

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
47

47 papers with at least that number of citations each

WoS: ESCIQ1
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
5articles/year
100% Gold OA•75% Original Research

Aims & Scope

Autoimmune Diseases (ISSN: 2090-0422) is a peer-reviewed international scholarly journal in the field of IMMUNOLOGY, published by Hindawi Limited in United Kingdom. The periodical holds tracked under Web of Science (ESCI) in quartile Q1, a Scopus SJR indicator of 0.611 (Q2), an H-index of 47.

Topics Covered (Recognized by AI)
Medicine99.6%Biology94.4%Internal medicine90%Immunology90%Genetics78.1%Pathology76.9%Disease64.5%Antibody51.4%Chemistry50.2%Biochemistry48.2%Psychology42.6%Psychiatry39.8%Immune system36.7%Endocrinology28.7%Surgery28.7%Gene23.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

13 year
2026Latest
IF—
Articles / Year21
Total Citations0
2025
IF1.7
Articles / Year—
Total Citations—
2024
IF4
Articles / Year6
Total Citations35
2023
IF—
Articles / Year1
Total Citations4
2022
IF—
Articles / Year9
Total Citations50

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,635Scopus Q2SCImago Profile
Scopus Coverage:2010-2024
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
0.611

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.50

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,953 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations38
3-Year Documents14
Citable Documents14

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate0.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Immunology and Microbiology (miscellaneous)Q2
ImmunologyQ3
Immunology and AllergyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Autoimmune Diseases (ISSN: 2090-0422) is a peer-reviewed international scholarly journal in the field of IMMUNOLOGY, published by Hindawi Limited in United Kingdom. The periodical holds tracked under Web of Science (ESCI) in quartile Q1, a Scopus SJR indicator of 0.611 (Q2), an H-index of 47.

The journal enforces rigorous peer evaluation with an annual output of approximately 5 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $2,953 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Hindawi Limited
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 67fa4218-48f3-4f59-b89e-6d85233e3aa4
Database Updated: 2026-10-01